Markets
MNK

Corium International (CORI) Jumps: Stock Moves Up 8.9%

Corium International, Inc.CORI was a big mover last session, as the company saw its shares rise almost 9% on the day. The upside was driven by positive top-line interim results from a Phase 1 clinical study evaluating Corplex™ Donepezil as a potential treatment of Alzheimer's. This also led to far more shares changing hands than in a normal session. Meanwhile, this reverses the downtrend for the company, as the stock is now down over 28% in the past one-month time frame.

The company has not seen any estimate revision in the past 30 days and the Zacks Consensus Estimate remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Corium International currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked med-generic drug stock is Mallinckrodt Public Limited Company MNK with a Zacks Rank #2 (Buy).

Is CORI going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

MALLINCKRODT PL (MNK): Free Stock Analysis Report

CORIUM INTRNTNL (CORI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MNK

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More